Table 1

Characteristics of the patients used for systemic antibody responses and opsonisation experiments

Ulcerative colitisCrohn’s disease
*Total number of patients. Age and sex data are for all patients (n = 51). Other data are for patients for whom clinical information was available (n = 46).
†Mean (range).
5-ASA, 5-aminosalicylic acid; IBD, inflammatory bowel disease.
n*2724
Sex (M/F)12/1511/13
Age (y)†46 (17–74)42 (23–72)
Duration of disease (y)†7.9 (0–24)5.8 (0–17)
Anatomical distribution16 Pancolitis9 Colon only
8 Left sided or distal2 Ileal only
11 Ileocolonic
5-ASA drugs147
Systemic or local steroids48
Immunosuppressants14
No IBD specific drugs67